Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alexis Hugentobler"'
Autor:
Alain Manrique, Rémi Sabatier, Gérard Bouvard, Alexis Hugentobler, Annette Belin, Denis Agostini, Gilles Grollier, Sylvie Costo
Publikováno v:
Médecine Nucléaire. 31:464-472
Resume L’insuffisance cardiaque s’accompagne de perturbations importantes du fonctionnement du systeme nerveux adrenergique, hyperactivation globale de ce systeme et modifications locales du systeme nerveux sympathique. La scintigraphie cardiaque
Autor:
Denis Agostini, Philippe Icard, Alexis Hugentobler, Gérard Bouvard, Emilie Porret, Jean-Philippe Lerochais, Gerard Zalcman, Franck Sobrio, Arnaud Halley
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 32:1026-1032
The purpose of the study was to compare ( 18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) and ( 99m)Tc-depreotide single-photon emission computed tomography (SPECT) in the diagnosis of malignancy of solitary pulmonary nodules (SPNs).
Autor:
Christiane Susini, Véronique Moullart, Christian Duhamel, Rachida Lebtahi, Jean Claude Barbare, Séverine Hommel, Alexis Hugentobler, Eric Nguyen-Khac, Jean Louis Dupas, Thomas Aparicio, B. Tramier, Céline Lobry, Jean Paul Joly, Isabelle Ollivier, Jean François Cadranel
Publikováno v:
Cancer Biology and Therapy
Cancer Biology and Therapy, Taylor & Francis, 2009, 8 (21), pp.2033-9
Cancer Biology and Therapy, 2009, 8 (21), pp.2033-9
Cancer Biology and Therapy, Taylor & Francis, 2009, 8 (21), pp.2033-9
Cancer Biology and Therapy, 2009, 8 (21), pp.2033-9
International audience; BACKGROUND: Somatostatin receptor scintigraphy (SRS) has been reported for receptor (SSTR) screening in advanced hepatocarcinoma (aHC) prior to somatostatin analogue treatment. AIMS: To evaluate SSTR screening with SRS in aHC
Autor:
Sona Balogova, Françoise Montravers, Alexis Hugentobler, Khaldoun Kerrou, B. Susini, Jean Lacau St Guily, Sophie Périé, Pierre El Chater, Jean-Noël Talbot, Dany Grahek
Publikováno v:
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 137(4)
Prospectively evaluate the impact of fluorodeoxyglucose-fluorine-18 positron emission tomography (FDG-PET) in the management of recurrence of advanced head and neck squamous cell carcinoma during the first year after treatment.Seventy patients were f